Cheong et al. showed that patients with phospho-PTEN have a shorter OS as compared to non-phospho-PTEN patients, demonstrating that PTEN inactivation, mediated by its C-tail phosphorylation, could be a poor prognostic factor in AML [114]. The gene discussed is PTEN; the disease is acute myeloid leukemia.